Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-06

FDA Approved: FUROSEMIDE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for the generic diuretic furosemide from Meitheal Pharmaceuticals Inc. under ANDA 212803.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

SUPPL AP for FUROSEMIDE (FUROSEMIDE)